JoVE
JoVE
Faculty Resource Center
Research
Behavior
Biochemistry
Biology
Bioengineering
Cancer Research
Chemistry
Developmental Biology
Engineering
Environment
Genetics
Immunology and Infection
Medicine
Neuroscience
JoVE Journal
JoVE Encyclopedia of Experiments
JoVE Chrome Extension
Education
Biology
Chemistry
Clinical
Engineering
Environmental Sciences
Pharmacology
Physics
Psychology
Statistics
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Quiz
JoVE Business
Videos Mapped to your Course
Authors
Librarians
High Schools
About
Sign-In
Sign In
Contact Us
Research
JoVE Journal
JoVE Encyclopedia of Experiments
Education
JoVE Core
JoVE Science Education
JoVE Lab Manual
High Schools
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
Close
Research
Behavior
Biochemistry
Bioengineering
Biology
Cancer Research
Chemistry
Developmental Biology
Engineering
Environment
Genetics
Immunology and Infection
Medicine
Neuroscience
Products
JoVE Journal
JoVE Encyclopedia of Experiments
Education
Biology
Chemistry
Clinical
Engineering
Environmental Sciences
Pharmacology
Physics
Psychology
Statistics
Products
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Quiz
JoVE Business
Videos Mapped to Your Course
Teacher Resources
Get in Touch
Instant Trial
Log In
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
Journal
/
Cancer Research
/
Reprogramming PDAC and Pancreatic Cells into Induced Pluripotent Stem Cells
/
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
JoVE Journal
Cancer Research
A subscription to JoVE is required to view this content.
Sign in or start your free trial.
JoVE Journal
Cancer Research
Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Reprogramming PDAC and Pancreatic Cells into Induced Pluripotent Stem Cells
DOI:
10.3791/65811-v
•
01:31 min
•
February 02, 2024
•
Amani Alshaikh
2
,
Dmytro Grygoryev
,
Dove Keith
,
Brett Sheppard
5
,
Rosalie C Sears
6
,
Jungsun Kim
6
,
Abdenour Soufi
1
Centre for Regenerative Medicine, Institute of Regeneration and Repair, Institute of Stem Cell Research
,
The University of Edinburgh
,
2
King Abdulaziz City for Science and Technology Health Sector (KACST)
,
3
Cancer Early Detection Advanced Research Center, Knight Cancer Institute
,
Oregon Health & Science University
,
4
Brenden-Colson Canter for Pancreatic Care
,
Oregon Health & Science University
,
5
Department of Surgery
,
Oregon Health & Science University
,
6
Department of Molecular & Medical Genetics
,
Oregon Health & Science University
Tags
Pancreatic Ductal Adenocarcinoma
Induced Pluripotent Stem Cells
IPSC Reprogramming
Cancer Epigenome
Pancreatic Intraepithelial Neoplasia
Early-detection Diagnostic Markers
Bicistronic Lentiviral Vectors
PDAC-derived IPSCs
Embed
ADD TO PLAYLIST
Usage Statistics
Related Videos
check_url/65811?article_type=v
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
check_url/65811?article_type=v
Lentivirus Preparation and Reprogramming Transduction for Pancreatic Ductal Adenocarcinoma Cells
check_url/65811?article_type=v
Preparation of iMEF Feeder Cells and Reprogramming Transduction for Induced Pluripotent Stem Cells
Read Article